Dolutegravir-based antiretroviral therapy does not reduce plasma levonorgestrel or medroxyprogesterone acetate concentrations among contraceptive users living with HIV compared with HIV-negative controls

被引：0

|

作者：

Ryan, Rebecca ^{[1
]}

Mussa, Aamirah ^{[1
]}

Bame, Bame ^{[1
]}

Bapabi, Mbapi ^{[1
]}

Moshashane, Neo ^{[1
]}

Mechie, Imogen ^{[1
]}

Ensor, Samuel ^{[1
]}

Ndlovu, Neo ^{[1
]}

Chakona, Shelby ^{[1
]}

Simon, Selebaleng ^{[1
]}

Tsuaneng, Maipelo ^{[1
]}

Else, Laura ^{[2
]}

Amara, Alieu ^{[2
]}

Tatipamula, Vinay ^{[2
]}

Dickinson, Laura ^{[2
]}

Khoo, Saye ^{[2
]}

Morroni, Chelsea ^{[3
]}

机构：

[1] Botswana Harvard Hlth Partnership, Botswana Sexual & Reprod Hlth Initiat, Gaborone, Botswana

[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool, Merseyside, England

[3] Univ Edinburgh, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P196

引用

收藏

页码：187 / 187

页数：1

相关论文

共 43 条

[41] Serum uric acid and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy: a comparative cross-sectional study
Waritu, Nuredin Chura
Nair, Suresh Kumar P.
Usure, Rashed Edris
Jemal, Mohammed
FRONTIERS IN MEDICINE, 2024, 11
[42] Serum Lipid Profiles, Blood Glucose, and High-Sensitivity C-Reactive Protein Levels Among People Living with HIV Taking Dolutegravir and Ritonavir-Boosted Atazanavir-Based Antiretroviral Therapy at Jimma University Medical Center, Southwest Ethiopia, 2021
Waritu, Nuredin Chura
Nair, Suresh Kumar P.
Birhan, Bihonegn
Adugna, Tesfaye
Awgichew, Gesese Bogale
Jemal, Mohammed
HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2024, 16 : 17 - 32
[43] No relevant difference in incident hypertension observed by gender, race, baseline BMI, or other key subgroups through week 96 among people living with HIV-1 (PLWH) receiving dolutegravir (DTG)-based regimens or comparator antiretroviral therapy (cART) in pooled randomized clinical trials
Patel, P.
Milinkovic, A.
Grove, R.
Govan, L.
McKenna, M.
DiMondi, V. P.
Henegar, C.
Wynne, B.
Payvandi, N.
Jones, B.
HIV MEDICINE, 2023, 24 : 219 - 220

← 1 2 3 4 5 →